Double conjugation with CD133 and EGFR aptamers promoted the entry of the Sali-loaded nanoparticles in H460 and A549 lung cancer cells and CSCs, achieving superior antitumor efficacy both in vitro and in vivo in tumor-bearing mice, compared to controls [82]. The gene discussed is EGFR; the disease is neoplasm.